Investors in Penumbra, Inc. (NYSE:PEN) had a good week, as its shares rose 8.6% to close at US$292 following the release of its yearly results. It was not a great result overall. While revenues of ...

Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' constant ...

Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP investors. Read more on PEN stock here.

Sales of $324.1 million, up 16.3% year over year (+16.9% in constant currency) and beating the consensus of $315.66 million. Adjusted EPS of 83 cents, beating the consensus of 67 cents. Revenue ...

Let’s dig into the relative performance of Penumbra (NYSE:PEN) and its peers as we unravel the now-completed Q1 medical devices & supplies - cardiology, neurology, vascular earnings season. The ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Wednesday reported first-quarter net income of $39.2 million. On a per-share basis… ...

Penumbra, Inc.'s Indigo Aspiration System with Lightning 7 and Lightning 12 have secured CE Mark and are now commercially available in Europe.